Introduction to co-production
In March 2025, Rare Disease Research UK hosted a webinar on co-production.
Rare Disease Research UK’s webinar discussed:
- What co-production really means in the context of rare disease research, How co-production is it delivered in practice
- How patient advocacy groups can influence and co-produce meaningful research
- What effective co-production of resources and materials look like from both researcher and contributor perspectives
Speakers on the webinar included:
- Laura Cowley (Rare Disease Research Network, Patient Led Research Hub)
- Allison Watson (Ring20 Research and Support)
- Dr Charlotte Tye (RDR UK mTOR Node, King’s College London)
- Claire Oliver (RDR UK mTOR co-production contributor)
The resource shared here is an external source that Beacon had no involvement in creating. Whilst we believe this resource will be of benefit to our community, we cannot verify the accuracy, completeness, or reliability of the information provided in this resource. Sharing this resource does not imply endorsement, approval, or affiliation, nor have we received any compensation or benefit in return for sharing it. Please exercise your own judgment, and if necessary, consult with a qualified professional when relying on external information.